论文部分内容阅读
目的探讨氨溴索治疗小儿毛细支气管炎的临床疗效。方法本文采用氨溴索超声雾化吸入治疗毛细支气管炎患儿,并与常规治疗的对照组进行疗效对比。结果对两组患儿的临床治疗效果进行统计分析发现治疗组的痊愈率和有效率均明显高于对照组(P<0.05)。另外,治疗组患儿的气促缓解、心率正常方面与对照组相比差异无统计学意义(P>0.05);而治疗组患儿的哮鸣音、湿啰音、咳嗽等临床特征消失时间与对照组相比差异有统计学意义(P<0.05)。结论在婴幼儿毛细支气管炎急性期采用盐酸氨溴索雾化吸入的治疗可以明显改善患儿的临床症状、疗效显著、缩短病程、副作用轻微,值得临床推广使用。
Objective To investigate the clinical efficacy of ambroxol in the treatment of pediatric bronchiolitis. Methods In this paper, inhalation of ambroxol ultrasonic inhalation treatment of children with bronchiolitis, and compared with the conventional treatment of the control group. Results The clinical effects of two groups of children were statistically analyzed and found that the cure rate and the effective rate were significantly higher in the treatment group than in the control group (P <0.05). In addition, there was no significant difference between the treatment group and the control group (P> 0.05), while the disappearance of wheezing, dampness, cough and other clinical features disappeared in the treatment group Compared with the control group, the difference was statistically significant (P <0.05). Conclusion In the acute stage of bronchiolitis in infants, inhalation of ambroxol hydrochloride inhalation can significantly improve the clinical symptoms of children with significant curative effect, shortening the course of the disease and minor side effects, which are worthy of clinical promotion and use.